Press release
RNAi Therapeutics Market Forecast Covering Growth Development Strategies till 2027 - Arbutus Biopharma Corporation, Silence Therapeutics, Rexahn Pharmaceuticals, Inc, F. Hoffmann-La Roche Ltd, Quark
The Insight Partners
RNA interference is a biological method in which molecules of RNA inhibit gene expression by neutralizing the targeted mRNA molecules. This method plays vital role in defending cells against virus. This technique is an innovative method which into the clinical trial phase, and various companies are seeking for the FDA and EU commission approval for their products and technologies. The RNAi therapeutic are formulated to treat diseases such as cancer, haemophilia, age related diseases, and others.
Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00007157?utm_source=OpenPR&utm_medium=Simran
The RNAi therapeutics market is forecasted to grow due to the key factors such as rising chronic diseases such as cancer, genetic disorders, and cardiovascular diseases among others. The growth of the market is also expected to grow due to rising technological development and growing FDA approvals for RNAi therapeutics. The growth of the market is expected to have growth opportunities in the emerging nations were healthcare facilities and developments are rising significantly.
The "Global RNAi Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of RNAi therapeutics market with detailed market segmentation by molecule type, application, route of administration, end user and geography. The global RNAi therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading RNAi therapeutics market players and offers key trends and opportunities in the market.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global RNAi therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The RNAi therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
Top Companies Listed are -
1. Alnylam Pharmaceuticals, Inc.
2. Sanofi
3. OLIX PHARMACEUTICALS, INC.
4. GlaxoSmithKline plc
5. Benitec Biopharma
6. Arbutus Biopharma Corporation
7. Silence Therapeutics
8. Rexahn Pharmaceuticals, Inc
9. F. Hoffmann-La Roche Ltd
10. Quark
The report also includes the profiles of key RNAi therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Buy Complete Report at https://www.theinsightpartners.com/sample/TIPRE00007157?utm_source=OpenPR&utm_medium=Simran
Contact us –
Phone : +1-646-491-9876
Email Id : sales@theinsightpartners.com
Website: https://www.theinsightpartners.com
About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi Therapeutics Market Forecast Covering Growth Development Strategies till 2027 - Arbutus Biopharma Corporation, Silence Therapeutics, Rexahn Pharmaceuticals, Inc, F. Hoffmann-La Roche Ltd, Quark here
News-ID: 1867854 • Views: …
More Releases from The Insight Partners
Supercritical Fluid Chromatography: A Guide to Understanding the Process
The increasing emphasis on sustainable and environmentally friendly analytical techniques is driving the supercritical fluid chromatography (SFC) market. SFC utilizes supercritical fluids, primarily carbon dioxide, which are less harmful than traditional organic solvents. This shift towards green chemistry aligns with global environmental regulations and the push for eco-friendly processes in laboratories and industries. As organizations seek to minimize their environmental impact, the adoption of SFC technology continues to grow, enhancing…
LEO Satellite Market SWOT Analysis and Growth Projections by 2031
The LEO Satellite Market is expected to register a CAGR of 11.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
Growing Demand for Global Connectivity: The increasing need for ubiquitous, high-speed internet access, particularly in remote and underserved regions, is a key driver for the LEO satellite market. LEO satellites, with their low latency and ability to provide…
Induction Sealing Machine Market Growth Opportunities, Top Countries Data, Futur …
"Induction Sealing Machine Market is growing at a High CAGR during the forecast period 2031. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market".
"Induction Sealing Machine Market Forecast to 2031" a detailed analysis report added by the insight partners. This report offers in-depth analysis of Instant Beverages Premix Market 6-7 Year Performance, Predictions, Market players Financial Performance, Strategic…
Modular Data Center Market Top Players, Growth Opportunities and Current Status …
An exclusive Modular Data Center Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Supply Chain Management Software Market research report provides depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
